Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Lateonset Multiple Sclerosis in Isfahan, Iran Pubmed



Etemadifar M2 ; Abtahi SH1, 3 ; Minagar A4 ; Akbari M1 ; Masaeli A2 ; Tabrizi N2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Neurology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Medical Students Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Neurology, Louisiana State University School of Medicine, Shreveport, LA, United States

Source: Archives of Iranian Medicine Published:2012


Abstract

Background: Multiple sclerosis (MS) typically affects young adults; however, the first symptoms can occur after age 50 and is classified as late-onset MS (LOMS). Methods: In this retrospective study, we extracted the records of 3522 MS patients (2716 females and 806 males) registered in the Isfahan MS Society (IMSS) from 2003 to 2010. Next, we searched for LOMS cases. We aimed to compare these cases with 1698 non-LOMS subjects also extracted from the IMSS database. Results: We found 48 LOMS patients (28 females and 20 males), which gave a crude frequency of 1.36%. The frequency by sex of LOMS in males (2.4%) was significantly greater than in females (1.0%, P = 0.002). The mean age at onset was 55.1 ± 4.3 years. The female to male ratio of 1.4:1 in these patients was significantly lower than in non-LOMS subjects (3.37:1, P = 0.003). The leading pattern of MS was relapsing-remitting (RR) in 62.5%, followed by primary progressive (PP) in 27.1%, and secondary progressive (SP) in 10.4%. Predominant presenting symptoms and signs were motor disturbances (35.4%), followed by brainstem (25%), optic neuritis (22.9%), and sensory related deficits (18.7%). The mean progression index (PI) in LOMS patients (0.88 ± 0.48) was significantly higher than in non-LOMS cases, 0.37 ± 0.17 (P< 0.0001). Discussion: In comparing LOMS patients with the non-LOMS cohort, there was a higher frequency of the PP pattern and a higher PI in the LOMS group. In comparing other high-risk populations with the Isfahan cohort, LOMS formed a lower percentage of the total Isfahan MS population.
Related Docs
View other Related Docs
1. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
2. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
3. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
4. Epidemiology of Multiple Sclerosis in Iran: A Systematic Review, European Neurology (2013)
5. Sex As a Determinant of Relapse Incidence and Progressive Course of Multiple Sclerosis, Brain (2013)
6. Estimated Prevalence and Incidence of Multiple Sclerosis in Iran, European Neurology (2014)
7. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
8. Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients, Journal of Child Neurology (2016)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (154)
Masoud Etemadifar (143)
Other Related Docs
9. Incidence and Prevalence of Multiple Sclerosis in Persian Gulf Area: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2020)
10. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
11. Male Sex Is Independently Associated With Faster Disability Accumulation in Relapse-Onset Ms But Not in Primary Progressive Ms, PLoS ONE (2015)
12. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
13. Clinical and Demographical Characteristics of Primary Progressive Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2007)
14. Characteristics of Familial Multiple Sclerosis in Isfahan, Iran: A Cross-Sectional Study, Neurology Asia (2014)
15. Better Prognosis of Multiple Sclerosis in Patients Who Experienced a Full-Term Pregnancy, European Neurology (2012)
16. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)
17. The Global Prevalence of Familial Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis, BMC Neurology (2021)
18. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
19. Pediatric Multiple Sclerosis With Primary Progressive Course-Report of a Retrospective Cohort Study in Iran, Neuropediatrics (2013)
20. Effectiveness of Bupropion on Sexual Dysfunction of Women With Multiple Sclerosis: A Clinical Trial, Iranian Journal of Obstetrics, Gynecology and Infertility (2021)
21. Psychological Well-Being in People With Multiple Sclerosis in an Iranian Population, Journal of Research in Medical Sciences (2015)
22. Seizure Characteristics in Multiple Sclerosis Patients, Journal of Research in Medical Sciences (2013)
23. Variability of the Response to Immunotherapy Among Subgroups of Patients With Multiple Sclerosis, European Journal of Neurology (2023)
24. Increasing Female Preponderance of Multiple Sclerosis in Isfahan, Iran: A Population-Based Study, Multiple Sclerosis (2010)
25. Sexual Dysfunction in Women With Multiple Sclerosis: Dimensions and Contributory Factors, Journal of Research in Medical Sciences (2014)
26. Linkage of Multiple Sclerosis and Guillain-Barre Syndrome: A Population-Based Survey in Isfahan, Iran, Autoimmune Diseases (2012)
27. The Role of Parental Consanguinity and Familial Aggregation in Development of Multiple Sclerosis: A Case-Control Study, European journal of medical research (2024)
28. Examining the Environmental Risk Factors of Progressive-Onset and Relapsing-Onset Multiple Sclerosis: Recruitment Challenges, Potential Bias, and Statistical Strategies, Journal of Neurology (2024)
29. Childhood-Onset Multiple Sclerosis: Report of 82 Patients From Isfahan, Iran, Archives of Iranian Medicine (2007)
30. Epileptic Seizures in Multiple Sclerosis: A Population-Based Survey in Iran, Acta Neurologica Belgica (2013)
31. Risk Factors of Early Onset of Ms in Women in Reproductive Age Period: Survival Analysis Approach, Archives of Women's Mental Health (2016)
32. Ongoing Increase in Incidence and Prevalence of Multiple Sclerosis in South-Eastern Iran: A Three Decade Study, Multiple Sclerosis and Related Disorders (2023)
33. Seasonal and Monthly Variation in Multiple Sclerosis Relapses: A Systematic Review and Meta-Analysis, Acta Neurologica Belgica (2022)
34. Investigating the Interaction Between Fertility, Pregnancy, and Multiple Sclerosis, Journal of Education and Health Promotion (2021)
35. Epidemiological and Clinical Features of Pediatric-Onset Multiple Sclerosis: A Population-Based Study in Isfahan, Iran, Between 1997-2020, Current Journal of Neurology (2021)
36. Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province, International Journal of Preventive Medicine (2016)
37. The Role of Information System in Multiple Sclerosis Management, Journal of Research in Medical Sciences (2014)
38. Multiple Sclerosis Epidemiology in Asia and Oceania; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
39. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
40. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)
41. First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis, Neurotherapeutics (2025)
42. Stress Differentially Predicts Multiple Sclerosis Relapses, Neurology Asia (2014)
43. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
44. Prevalence of Multiple Sclerosis (Ms) in Iran: A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
45. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
46. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
47. The Frequency of Cognitive Dysfunction Among Multiple Sclerosis Patients With Mild Physical Disability, Journal of Isfahan Medical School (2012)
48. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
49. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)
50. Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients, International Journal of Preventive Medicine (2023)